Research Article

The in silico interaction analysis of CARMIL1 protein-containing leucine-rich repeat (LRR) regions with interleukin-1 receptor-associated kinase 1 (IRAK1) protein and LLR peptide

Volume: 8 Number: 6 November 4, 2022
EN

The in silico interaction analysis of CARMIL1 protein-containing leucine-rich repeat (LRR) regions with interleukin-1 receptor-associated kinase 1 (IRAK1) protein and LLR peptide

Abstract

Objectives: Capping protein Arp2/3 and myosin-I linker protein 1 (CARMIL1) encoded by the CARMIL, is a major, multidomain, membrane-linked protein regulating actin assembly; however, its function in inflammatory signaling is not fully elucidated. The leucine-rich repeat (LRR) region of CARMIL1 has been associated with interleukin (IL)-1 receptor-associated kinase (IRAK) in fibroblasts by many methods including tandem mass tag mass spectrometry, immunoprecipitation, and CRISPR-Cas9. This study, therefore, set out to assess the interaction of CARMIL1 with each IRAK1 protein and a novel LRR peptide.

Methods: The molecular docking techniques were employed to compare the binding modes and affinities of the 3D structure of CARMIL1 each of LRR peptides and IRAK1 protein. 3D structure model of CARMIL1 protein and LRR peptide was predicted through Robetta tool considering the structures and function of these proteins.

Results: As an overall conclusion of docking, the LRR peptide was observed to contact the residues in the LRR 1-2 of the human CARMIL1, whereas the IRAK1 protein was to interact with the residues in the LRR 1, 2, and 10 regions of the human CARMIL1.

Conclusions: Our computational results suggest that LRRs in CARMIL1 are involved in the formation of protein-peptide binding interfaces with its structural conformation.

Keywords

References

  1. 1. Hönig J, Rordorf-Adam C, Siegmund C, Wiedemann W, Erard F. Increased interleukin-1 beta (IL-1 beta) concentration in gingival tissue from periodontitis patients. J Periodontal Res 1989;24:362-7.
  2. 2. Muzio M, Ni J, Feng P, Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997;278:1612-5.
  3. 3. MacGillivray MK, Cruz TF, McCulloch CAG. The recruitment of the interleukin-1 (IL-1) receptor-associated kinase (IRAK) into focal adhesion complexes is required for IL-1beta-induced ERK activation. J Biol Chem 2000;275:23509-15.
  4. 4. Arora PD, Ma J, Min W, Cruz T, McCulloch CAG. Interleukin-1-induced calcium flux in human fibroblasts is mediated through focal adhesions. J Biol Chem 1995;270:6042-9.
  5. 5. Lo YYC, Luo L, McCulloch CAG, Cruz TF. Requirements of focal adhesions and calcium fluxes for interleukin-1-induced ERK kinase activation and c-fos expression in fibroblasts. J Biol Chem 1998;273:7059-65.
  6. 6. Wang Q, Rajshankar D, Laschinger C, Talior-Volodarsky I, Wang Y, Downey GP, et al. Importance of protein-tyrosine phosphatase-alfa catalytic domains for interactions with SHP-2 and interleukin-1-induced matrix metalloproteinase-3 expression. J Biol Chem 2010;285:22308-17.
  7. 7. Stark BC, Lanier MH, Cooper JA. CARMIL family proteins as multidomain regulators of actin-based motility. Mol Biol Cell 2017;28:1713-23.
  8. 8. Yang C, Pring M, Wear MA, Huang M, Cooper JA, Svitkina TM, et al. Mammalian CARMIL inhibits actin filament capping by capping protein. Dev Cell 2005;9:209-21.

Details

Primary Language

English

Subjects

Biochemistry and Cell Biology (Other)

Journal Section

Research Article

Publication Date

November 4, 2022

Submission Date

October 18, 2021

Acceptance Date

June 21, 2022

Published in Issue

Year 2022 Volume: 8 Number: 6

APA
Beşli, N., & Yenmiş, G. (2022). The in silico interaction analysis of CARMIL1 protein-containing leucine-rich repeat (LRR) regions with interleukin-1 receptor-associated kinase 1 (IRAK1) protein and LLR peptide. The European Research Journal, 8(6), 810-820. https://doi.org/10.18621/eurj.1011372
AMA
1.Beşli N, Yenmiş G. The in silico interaction analysis of CARMIL1 protein-containing leucine-rich repeat (LRR) regions with interleukin-1 receptor-associated kinase 1 (IRAK1) protein and LLR peptide. Eur Res J. 2022;8(6):810-820. doi:10.18621/eurj.1011372
Chicago
Beşli, Nail, and Güven Yenmiş. 2022. “The in Silico Interaction Analysis of CARMIL1 Protein-Containing Leucine-Rich Repeat (LRR) Regions With Interleukin-1 Receptor-Associated Kinase 1 (IRAK1) Protein and LLR Peptide”. The European Research Journal 8 (6): 810-20. https://doi.org/10.18621/eurj.1011372.
EndNote
Beşli N, Yenmiş G (November 1, 2022) The in silico interaction analysis of CARMIL1 protein-containing leucine-rich repeat (LRR) regions with interleukin-1 receptor-associated kinase 1 (IRAK1) protein and LLR peptide. The European Research Journal 8 6 810–820.
IEEE
[1]N. Beşli and G. Yenmiş, “The in silico interaction analysis of CARMIL1 protein-containing leucine-rich repeat (LRR) regions with interleukin-1 receptor-associated kinase 1 (IRAK1) protein and LLR peptide”, Eur Res J, vol. 8, no. 6, pp. 810–820, Nov. 2022, doi: 10.18621/eurj.1011372.
ISNAD
Beşli, Nail - Yenmiş, Güven. “The in Silico Interaction Analysis of CARMIL1 Protein-Containing Leucine-Rich Repeat (LRR) Regions With Interleukin-1 Receptor-Associated Kinase 1 (IRAK1) Protein and LLR Peptide”. The European Research Journal 8/6 (November 1, 2022): 810-820. https://doi.org/10.18621/eurj.1011372.
JAMA
1.Beşli N, Yenmiş G. The in silico interaction analysis of CARMIL1 protein-containing leucine-rich repeat (LRR) regions with interleukin-1 receptor-associated kinase 1 (IRAK1) protein and LLR peptide. Eur Res J. 2022;8:810–820.
MLA
Beşli, Nail, and Güven Yenmiş. “The in Silico Interaction Analysis of CARMIL1 Protein-Containing Leucine-Rich Repeat (LRR) Regions With Interleukin-1 Receptor-Associated Kinase 1 (IRAK1) Protein and LLR Peptide”. The European Research Journal, vol. 8, no. 6, Nov. 2022, pp. 810-2, doi:10.18621/eurj.1011372.
Vancouver
1.Nail Beşli, Güven Yenmiş. The in silico interaction analysis of CARMIL1 protein-containing leucine-rich repeat (LRR) regions with interleukin-1 receptor-associated kinase 1 (IRAK1) protein and LLR peptide. Eur Res J. 2022 Nov. 1;8(6):810-2. doi:10.18621/eurj.1011372